2 completed, 1 recruiting. 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow apaflurane: new trials by email Literature Review of apaflurane trials Research Report on apaflurane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Advair HFA in Healthy and HAPE Predisposed Subjects Advair HFA, Placebo - Altitude Edema | Phase 1 / Phase 2 | Recruiting | University of Colorado, Denver | 60 | 2023-12-12 | 2025-09-22 |
| Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype Albuterol, Technetium99m - Sulfur Colloid (Tc99m-SC) - Primary Ciliary Dyskinesia | Early Phase 1 | Completed | University of North Carolina, Chapel Hill | 27 | 2021-06-10 | 2025-09-05 |
| Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies BDP HFA, Placebo nasal aerosol - Seasonal Allergic Rhinitis, SAR | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 715 | 2011-03-01 | 2015-02-20 |
Altitude Sickness (1) · Ciliary Motility Disorders (1) · Hypersensitivity (1) · Hypoxia (1) · Rhinitis, Allergic, Seasonal (1)
Teva Branded Pharmaceutical Products R&D, Inc. (1) · University of Colorado, Denver (1) · University of North Carolina, Chapel Hill (1)
United States (3)
James P Maloney, MD (1) · Lawrence Ostrowski, PhD (1)
R01HL117836 (1)